Actively Recruiting
Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
Led by Medical University of Bialystok · Updated on 2026-04-14
90
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with lung cancer often have reduced physical fitness and coexisting health problems, which may limit their ability to tolerate oncological treatment. Standard resting lung and heart tests do not always reflect real-life physical capacity during everyday activities or physical effort. This observational study aims to assess cardiorespiratory fitness in patients with lung cancer before and during standard oncological treatment using cardiopulmonary exercise testing (CPET). CPET is a safe, supervised exercise test that provides objective information on how the heart, lungs, and muscles respond to physical effort. Participants with WHO/ECOG performance status 0-2 will undergo CPET before treatment initiation and again after the early phase of therapy or surgery. The results may help identify patients with reduced physiological reserve and support individualized monitoring during routine clinical care.
CONDITIONS
Official Title
Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age ≥ 18 years
- Histologically confirmed lung cancer (any stage)
- Qualified for standard oncological management (surgery and/or systemic therapy)
- WHO/ECOG performance status 0-2
- Ability to perform cardiopulmonary exercise testing (CPET)
- Written informed consent
You will not qualify if you...
- Unstable ischemic heart disease
- Symptomatic cardiac arrhythmias
- Myocarditis or pericarditis
- Decompensated heart failure
- Active deep vein thrombosis
- Suspected aortic dissection or severe aortic stenosis
- Poorly controlled asthma
- Resting oxygen saturation ≤ 85% on room air
- Clinically relevant treatment-related adverse events above mild intensity (as applicable)
- Any medical condition that, in the investigator's opinion, precludes safe participation in CPET
- Withdrawal of informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Clinical Hospital in Bialystok, II Department of Pulmonology, Lung Cancer and Internal Medicine, Medical University of Bialystok
Bialystok, Podlaskie Voivodeship, Poland, 15-276
Actively Recruiting
Research Team
K
Klaudia Jadczak, Medical Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here